Yingcong Li

Yingcong Li

Auto-generated profile, based on publicly available information

Yingcong Li

La Jolla Institute for Immunology, La Jolla, USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 May 2022 in Nature
Verified
Journal Article
Open access
PDF file
SESimon Eschweiler
Simon Eschweiler
CRCiro Ramírez-Suástegui
Ciro Ramírez-Suástegui
YLYingcong Li
Yingcong Li
EKEmma King
Emma King
LCLindsey Chudley
Lindsey Chudley
COChristian H. Ottensmeier
Christian H. Ottensmeier
Phosphoinositide 3-kinase δ (PI3Kδ) has a key role in lymphocytes, and inhibitors that target this PI3K have been approved for treatment of B cell malignancies1–3. Although studies in mouse models of solid tumours have demonstrated that PI3Kδ inhibitors (PI3Kδi) can induce anti-tumour immunity4,5, its effect on solid tumours in humans remains unclear. Here we assessed the effects of the PI3Kδi AMG319 in human patients with head and neck cancer in a neoadjuvant, double-blind, placebo-controlled randomized phase II trial (EudraCT no. 2014-004388-20). PI3Kδ inhibition decreased the number of tumour-infiltrating regulatory T (Treg) cells and enhanced the cytotoxic potential of tumour-infiltrating T cells. At the tested doses of AMG319, immune-related adverse events (irAEs) required treatment to be discontinued in 12 out of 21 of patients treated with AMG319, suggestive of systemic effects on Treg cells. Accordingly, in mouse models, PI3Kδi decreased the number of Treg cells systemically and caused colitis. Single-cell RNA-sequencing analysis revealed a PI3Kδi-driven loss of tissue-resident colonic ST2 Treg cells, accompanied by expansion of pathogenic T helper 17 (TH17) and type 17 CD8+ T (TC17) cells, which probably contributed to toxicity; this points towards a specific mode of action for the emergence of irAEs. A modified treatment regimen with intermittent dosing of PI3Kδi in mouse models led to a significant decrease in tumour growth without inducing pathogenic T cells in colonic tissue, indicating that alternative dosing regimens might limit toxicity.

24 November 2023 in Science Immunology
Verified
Journal Article
Closed access
SCShilpi Chandra
Shilpi Chandra
GAGabriel Ascui
Gabriel Ascui
TRThomas Riffelmacher
Thomas Riffelmacher
ACAshu Chawla
Ashu Chawla
CRCiro Ramírez-Suástegui
Ciro Ramírez-Suástegui
MKMitchell Kronenberg
Mitchell Kronenberg
Mucosal-associated invariant T (MAIT) cells are a subset of T lymphocytes that respond to microbial metabolites. We defined MAIT cell populations in different organs and characterized the developmental pathway of mouse and human MAIT cells in the thymus using single-cell RNA sequencing and phenotypic and metabolic analyses. We showed that the predominant mouse subset, which produced IL-17 (MAIT17), and the subset that produced IFN-γ (MAIT1) had not only greatly different transcriptomes but also different metabolic states. MAIT17 cells in different organs exhibited increased lipid uptake, lipid storage, and mitochondrial potential compared with MAIT1 cells. All these properties were similar in the thymus and likely acquired there. Human MAIT cells in lung and blood were more homogeneous but still differed between tissues. Human MAIT cells had increased fatty acid uptake and lipid storage in blood and lung, similar to human CD8 T resident memory cells, but unlike mouse MAIT17 cells, they lacked increased mitochondrial potential. Although mouse and human MAIT cell transcriptomes showed similarities for immature cells in the thymus, they diverged more strikingly in the periphery. Analysis of pet store mice demonstrated decreased lung MAIT17 cells in these so-called “dirty” mice, indicative of an environmental influence on MAIT cell subsets and function.

19 June 2024 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
YLYingcong Li
Yingcong Li
CRCiro Ramírez-Suástegui
Ciro Ramírez-Suástegui
RHRichard Harris
Richard Harris
FCFrancisco Emmanuel Castañeda-Castro
Francisco Emmanuel Castañeda-Castro
GAGabriel Ascui
Gabriel Ascui
PVPandurangan Vijayanand
Pandurangan Vijayanand

15 March 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
YLYingcong Li
Yingcong Li
GAGabriel Ascui
Gabriel Ascui
MDMartina Dicker
Martina Dicker
TRThomas Riffelmacher
Thomas Riffelmacher
VCVivek Chandra
Vivek Chandra
MKMitchell Kronenberg
Mitchell Kronenberg
Genome wide association studies (GWAS) identify many risks for Crohn’s disease (CD), including a site near the metabolism gene laccase domain containing 1 (LACC1). We previously found this site near LACC1 was associated with decreased LACC1 expression in T lymphocytes, yet the mechanism affecting gene expression and its links to T cell function and inflammatory disease were unknown. Here we identify variants in the promoter region that influence transcription of LACC1. Direct association of disease-risk variants with lower LACC1 pre-mRNA in human CD4+ T cells is confirmed by comparing transcripts from each allele from donors heterozygous for the LACC1 CD-risk allele. Using gene editing, we validate the function of this promoter region in LACC1 expression in T cells. Human CD4+ T cells with LACC1 gene knockdown show altered metabolism, including reduced oxygen consumption rate, and reduced in vitro regulatory T cell differentiation. Therefore, our study provides a mechanism linking these specific LACC1 variants to colitis by attributing promoter region variants to changes in T cell metabolism and function.

25 February 2026 in Nature Structural & Molecular Biology
Verified
Journal Article
Open access
YCYoungseo Cheon
Youngseo Cheon
EAErik Glen Alvstad
Erik Glen Alvstad
DTDenis Torre
Denis Torre
DQDaniel Tu Quach
Daniel Tu Quach
JNJennifer Nguyen
Jennifer Nguyen
IMIvan Marazzi
Ivan Marazzi
Transposable elements (TEs) in the human genome are the heritage of ancient parasitic infections. While most of human DNA comprises TEs and TE-derived elements, their repetitive nature poses technical challenges; thus, little is known about their positional identity and regulatory roles. Here, by integrating long-read and multidimensional transcriptional analyses, we investigate when, where and how TEs become part of a gene. We characterize how TE-derived isoforms change across mouse–human variation and how they are linked to gene regulatory networks controlling cell states during differentiation, organogenesis and health (aging and pathological states). Mechanistically, we identify an RNA degradation-dependent and splicing-dependent quality control mechanism that operates independently of conventional mechanisms of TE suppression, such as DNA methylation and heterochromatinization, and prevents TE-chimera expression and TE-induced cell differentiation. Overall, our findings unveil mechanisms by which viral-derived elements enhance transcriptome plasticity.